Stockscreener 앱 받기
29.20
1.17%
0.3369
시간 외 거래:
29.39
0.1902
+0.65%
전일 마감가:
$28.86
열려 있는:
$28.8
하루 거래량:
1,093
Relative Volume:
0.27
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.14%
1개월 성능:
-0.14%
6개월 성능:
-7.02%
1년 성능:
-1.08%
1일 변동 폭
$28.80
$29.39
1주일 범위
$28.68
$30.81
52주 변동 폭
$28.30
$33.98
Franklin Genomic Advancements Etf Stock (HELX) Company Profile
HELX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HELX
Franklin Genomic Advancements Etf
|
29.20 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
293.28 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
591.15 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
593.33 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
242.75 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
518.66 | 124.43B | 0 | 0 | 0 | 0.00 |
Franklin Genomic Advancements Etf 주식(HELX)의 최신 뉴스
(HELX) On The My Stocks Page - Stock Traders Daily
Worst performing ETFs this week: Technology ETFs - Trackinsight
(HELX) Investment Analysis - Stock Traders Daily
(HELX) Investment Analysis and Advice - Stock Traders Daily
Trading (HELX) With Integrated Risk Controls - Stock Traders Daily
Trend Tracker for (HELX) - Stock Traders Daily
(HELX) Trading Advice - Stock Traders Daily
2,250 Shares in CONSOL Energy Inc. (NYSE:CEIX) Purchased by Commonwealth Equity Services LLC - Defense World
(HELX) Technical Data - Stock Traders Daily
Where are the Opportunities in (HELX) - Stock Traders Daily
7 Best-Performing Biotech ETFs for July 2024 - NerdWallet
From AI drones to robots, this fund manager focuses on life-changing technology - MarketWatch
5 Best Performing Biotech ETFs in 2024 - Insider Monkey
ARK reveals the first European Ucits ETFs - RankiaPro En
Franklin Templeton Launches Franklin Focused Growth ETF (FFOG) - Yahoo Finance
12 Best Biotech ETFs To Buy - Yahoo Finance
Revvity (RVTY) Stock Price, News & AnalysisNYSE - MarketBeat
Franklin forges ahead with legal battle over gold ETF - Citywire
Revealed: The best-performing tech managers of Q2 - Citywire Selector
Franklin Templeton launches three thematic funds - Funds Europe Magazine
Technology Could Boost The NPV Of Biopharmaceutical Pipeline Assets Significantly - Seeking Alpha
5 ETFs Riding the Growth Comeback Euphoria - Yahoo Finance
How to Invest in Innovation - International Banker
Robinhood Army Propels Thematic ETFs to a Record-Setting Year - Bloomberg
Franklin Templeton Gives Matt Moberg Three New Funds To Run - Investor's Business Daily
The Year of the Active ETF - Wealth Management
Investing in Innovation - Wealth Management
Thematic ETFs need careful evaluation… - ETF Express
BioNTech (BNTX) Stock Price, News & Analysis - MarketBeat
Avantor (AVTR) Stock Price, News & Analysis - MarketBeat
Qiagen (QGEN) Stock Price, News & AnalysisNYSE - MarketBeat
Krystal Biotech (KRYS) Stock Price, News & Analysis - MarketBeat
Voyager Therapeutics (VYGR) Stock Price, News & Analysis - MarketBeat
Natera (NTRA) Stock Price, News & AnalysisNASDAQ - MarketBeat
Ionis Pharmaceuticals (IONS) Stock Price, News & Analysis - MarketBeat
Bio-Rad Laboratories (BIO) Stock Price, News & Analysis - MarketBeat
Regeneron Pharmaceuticals (REGN) Stock Price, News & Analysis - MarketBeat
Ligand Pharmaceuticals (LGND) Stock Price, News & Analysis - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock Price, News & Analysis - MarketBeat
Franklin Genomic Advancements Etf (HELX) 재무 분석
Franklin Genomic Advancements Etf (HELX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.17%
0.28%
자본화:
|
볼륨(24시간):